CAS ID: | 191732-72-6 |
Molecular Formula: | C13H13N3O3 |
Molecular Weight: | 259.3 g/mol |
Monoisotopic Mass: | 259.0957 g/mol |
Class: | Small Molecule |
Natural Product: | No |
Other Names: | REVLIMID | CDC-501 | CC-5013 | LENALIDOMIDE |
Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
PubMed ID | 26088933 | Target ID | |
Uniprot ID | Name | ||
Model | human | Fibrosis Disease | Bone marrow fibrosis |
Process I | |||
Process II | |||
Process III | |||
Mechanism |
Trial Record 1
ClinicalTrial ID | NCT02705638 | Disease | Retroperitoneal fibrosis |
Phase | Phase 1 | Status | Active, not recruiting |
First Received | March 10, 2016 | Last Verified | February 12, 2019 |
Sponsor | Mayo Clinic |